Effects of anthracycline therapy on intestinal absorption in patients with advanced breast cancer

G. Parrilli, R. V. Iaffaioli, M. Martorano, R. Cuomo, S. Tafuto, M. G. Zampino, G. Budillon, A. R. Bianco

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Although cytotoxic chemotherapy for human cancer has been reported to induce alterations in intestinal permeability, its effects on the absorptive process are still controversial. We have studied mediated and nonmediated absorption in 10 patients with metastatic breast cancer before and after treatment with Adriamycin by the use of specific test sugars given orally and their subsequent urinary recovery, as measured by chromatography. Mediated absorption was investigated by the use of D-xylose and 3-O-methylglucose, while lactulose and L-rhamnose were used to study nonmediated permeation. Laculose is considered a marker of unmediated paracellular (tight junction) permeation, while L-rhamnose explores passage across cell membranes. The test was performed on patients before and on the second and the eighth days after Adriamycin administration, and only once in 22 age-matched healthy women. Under basal conditions, as well as 2 and 8 days after chemotherapy, D-xylose and 3-O-methylglucose absorption was 35% lower in patients than in controls (P <0.001). Lactulose absorption was significantly higher in patients than in controls under basal conditions (P <0.001); it reached levels three times higher the second day after chemotherapy, and returned to basal levels by the eighth day. The data suggest an early reversible effect of Adriamycin on cellular tight junctions with resulting increased permeabilization. This effect seems of a toxic nature rather than due to increased cell loss. It is interesting that both nonmediated absorption and mediated absorption were already altered before chemotherapy in cancer patients, suggesting a preexisting functional damage of the intestine. The significance of this alteration as a potential mechanism of cancer cachexia is discussed.

Original languageEnglish
Pages (from-to)3689-3691
Number of pages3
JournalCancer Research
Volume49
Issue number13
Publication statusPublished - 1989

Fingerprint

Anthracyclines
Intestinal Absorption
Breast Neoplasms
3-O-Methylglucose
Doxorubicin
Lactulose
Drug Therapy
Rhamnose
Tight Junctions
Xylose
Therapeutics
Neoplasms
Cachexia
Poisons
Intestines
Chromatography
Permeability
Cell Membrane

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Parrilli, G., Iaffaioli, R. V., Martorano, M., Cuomo, R., Tafuto, S., Zampino, M. G., ... Bianco, A. R. (1989). Effects of anthracycline therapy on intestinal absorption in patients with advanced breast cancer. Cancer Research, 49(13), 3689-3691.

Effects of anthracycline therapy on intestinal absorption in patients with advanced breast cancer. / Parrilli, G.; Iaffaioli, R. V.; Martorano, M.; Cuomo, R.; Tafuto, S.; Zampino, M. G.; Budillon, G.; Bianco, A. R.

In: Cancer Research, Vol. 49, No. 13, 1989, p. 3689-3691.

Research output: Contribution to journalArticle

Parrilli, G, Iaffaioli, RV, Martorano, M, Cuomo, R, Tafuto, S, Zampino, MG, Budillon, G & Bianco, AR 1989, 'Effects of anthracycline therapy on intestinal absorption in patients with advanced breast cancer', Cancer Research, vol. 49, no. 13, pp. 3689-3691.
Parrilli, G. ; Iaffaioli, R. V. ; Martorano, M. ; Cuomo, R. ; Tafuto, S. ; Zampino, M. G. ; Budillon, G. ; Bianco, A. R. / Effects of anthracycline therapy on intestinal absorption in patients with advanced breast cancer. In: Cancer Research. 1989 ; Vol. 49, No. 13. pp. 3689-3691.
@article{78701a0c449b43f1a83b5d8f1afcb1bf,
title = "Effects of anthracycline therapy on intestinal absorption in patients with advanced breast cancer",
abstract = "Although cytotoxic chemotherapy for human cancer has been reported to induce alterations in intestinal permeability, its effects on the absorptive process are still controversial. We have studied mediated and nonmediated absorption in 10 patients with metastatic breast cancer before and after treatment with Adriamycin by the use of specific test sugars given orally and their subsequent urinary recovery, as measured by chromatography. Mediated absorption was investigated by the use of D-xylose and 3-O-methylglucose, while lactulose and L-rhamnose were used to study nonmediated permeation. Laculose is considered a marker of unmediated paracellular (tight junction) permeation, while L-rhamnose explores passage across cell membranes. The test was performed on patients before and on the second and the eighth days after Adriamycin administration, and only once in 22 age-matched healthy women. Under basal conditions, as well as 2 and 8 days after chemotherapy, D-xylose and 3-O-methylglucose absorption was 35{\%} lower in patients than in controls (P <0.001). Lactulose absorption was significantly higher in patients than in controls under basal conditions (P <0.001); it reached levels three times higher the second day after chemotherapy, and returned to basal levels by the eighth day. The data suggest an early reversible effect of Adriamycin on cellular tight junctions with resulting increased permeabilization. This effect seems of a toxic nature rather than due to increased cell loss. It is interesting that both nonmediated absorption and mediated absorption were already altered before chemotherapy in cancer patients, suggesting a preexisting functional damage of the intestine. The significance of this alteration as a potential mechanism of cancer cachexia is discussed.",
author = "G. Parrilli and Iaffaioli, {R. V.} and M. Martorano and R. Cuomo and S. Tafuto and Zampino, {M. G.} and G. Budillon and Bianco, {A. R.}",
year = "1989",
language = "English",
volume = "49",
pages = "3689--3691",
journal = "Journal of Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "13",

}

TY - JOUR

T1 - Effects of anthracycline therapy on intestinal absorption in patients with advanced breast cancer

AU - Parrilli, G.

AU - Iaffaioli, R. V.

AU - Martorano, M.

AU - Cuomo, R.

AU - Tafuto, S.

AU - Zampino, M. G.

AU - Budillon, G.

AU - Bianco, A. R.

PY - 1989

Y1 - 1989

N2 - Although cytotoxic chemotherapy for human cancer has been reported to induce alterations in intestinal permeability, its effects on the absorptive process are still controversial. We have studied mediated and nonmediated absorption in 10 patients with metastatic breast cancer before and after treatment with Adriamycin by the use of specific test sugars given orally and their subsequent urinary recovery, as measured by chromatography. Mediated absorption was investigated by the use of D-xylose and 3-O-methylglucose, while lactulose and L-rhamnose were used to study nonmediated permeation. Laculose is considered a marker of unmediated paracellular (tight junction) permeation, while L-rhamnose explores passage across cell membranes. The test was performed on patients before and on the second and the eighth days after Adriamycin administration, and only once in 22 age-matched healthy women. Under basal conditions, as well as 2 and 8 days after chemotherapy, D-xylose and 3-O-methylglucose absorption was 35% lower in patients than in controls (P <0.001). Lactulose absorption was significantly higher in patients than in controls under basal conditions (P <0.001); it reached levels three times higher the second day after chemotherapy, and returned to basal levels by the eighth day. The data suggest an early reversible effect of Adriamycin on cellular tight junctions with resulting increased permeabilization. This effect seems of a toxic nature rather than due to increased cell loss. It is interesting that both nonmediated absorption and mediated absorption were already altered before chemotherapy in cancer patients, suggesting a preexisting functional damage of the intestine. The significance of this alteration as a potential mechanism of cancer cachexia is discussed.

AB - Although cytotoxic chemotherapy for human cancer has been reported to induce alterations in intestinal permeability, its effects on the absorptive process are still controversial. We have studied mediated and nonmediated absorption in 10 patients with metastatic breast cancer before and after treatment with Adriamycin by the use of specific test sugars given orally and their subsequent urinary recovery, as measured by chromatography. Mediated absorption was investigated by the use of D-xylose and 3-O-methylglucose, while lactulose and L-rhamnose were used to study nonmediated permeation. Laculose is considered a marker of unmediated paracellular (tight junction) permeation, while L-rhamnose explores passage across cell membranes. The test was performed on patients before and on the second and the eighth days after Adriamycin administration, and only once in 22 age-matched healthy women. Under basal conditions, as well as 2 and 8 days after chemotherapy, D-xylose and 3-O-methylglucose absorption was 35% lower in patients than in controls (P <0.001). Lactulose absorption was significantly higher in patients than in controls under basal conditions (P <0.001); it reached levels three times higher the second day after chemotherapy, and returned to basal levels by the eighth day. The data suggest an early reversible effect of Adriamycin on cellular tight junctions with resulting increased permeabilization. This effect seems of a toxic nature rather than due to increased cell loss. It is interesting that both nonmediated absorption and mediated absorption were already altered before chemotherapy in cancer patients, suggesting a preexisting functional damage of the intestine. The significance of this alteration as a potential mechanism of cancer cachexia is discussed.

UR - http://www.scopus.com/inward/record.url?scp=0024360433&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024360433&partnerID=8YFLogxK

M3 - Article

VL - 49

SP - 3689

EP - 3691

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0008-5472

IS - 13

ER -